Immunotherapy with alloreactive T-cells?
Madrigal
Alejandro J
AJ
Anthony Nolan Research Institue, London, UK.
Rusakiewicz
Sylvie
S
Dodi
Anthony I
AI
Rees
Robert
R
D000595:Amino Acid Sequence; D017951:Antigen Presentation; D000951:Antigens, Neoplasm / Q000276:immunology; D016044:Fusion Proteins, bcr-abl / Q000378:metabolism; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control; D020544:Graft vs Leukemia Effect; D015791:HLA-A3 Antigen / Q000378:metabolism; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016219:Immunotherapy, Adoptive; D007519:Isoantigens / Q000276:immunology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000628:therapy; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000628:therapy; D010446:Peptide Fragments / Q000276:immunology / Q000378:metabolism; D025941:Protein Interaction Mapping; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000637:transplantation*
D000951:Antigens, Neoplasm; D015791:HLA-A3 Antigen; D007519:Isoantigens; D010446:Peptide Fragments; D016044:Fusion Proteins, bcr-abl